Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014648
Filing Date
2024-11-06
Accepted
2024-11-06 16:31:28
Documents
90
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20240930x10q.htm   iXBRL 10-Q 3030595
2 EX-31.1 chrs-20240930xex31d1.htm EX-31.1 14074
3 EX-31.2 chrs-20240930xex31d2.htm EX-31.2 14967
4 EX-32.1 chrs-20240930xex32d1.htm EX-32.1 12076
  Complete submission text file 0001558370-24-014648.txt   12369276

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20240930.xsd EX-101.SCH 86829
6 EX-101.CAL chrs-20240930_cal.xml EX-101.CAL 93591
7 EX-101.DEF chrs-20240930_def.xml EX-101.DEF 394184
8 EX-101.LAB chrs-20240930_lab.xml EX-101.LAB 679338
9 EX-101.PRE chrs-20240930_pre.xml EX-101.PRE 560619
93 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240930x10q_htm.xml XML 2262685
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 241431553
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)